These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 11688968)
41. [A clinical study of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for liver metastases]. Ichihara T; Tenma K; Itoh M; Hibino M; Kikuchi I; Sasaki Y; Hosono Y; Nakamura M Gan To Kagaku Ryoho; 2003 Aug; 30(8):1143-5. PubMed ID: 12938270 [TBL] [Abstract][Full Text] [Related]
43. [Pharmacology of regional chemotherapy of colorectal liver metastases]. Schalhorn A; Kühl M Zentralbl Chir; 1995; 120(10):764-8. PubMed ID: 7502590 [TBL] [Abstract][Full Text] [Related]
44. Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the 133Xe-clearance technique. Oman M; Tölli J; Naredi P; Hafström LO Cancer Chemother Pharmacol; 2004 Sep; 54(3):213-8. PubMed ID: 15138707 [TBL] [Abstract][Full Text] [Related]
45. [Two cases of multiple liver metastases from colorectal cancer which responded well to hepatic arterial infusion (HAI) using 5-fluorouracil and l-leucovorin]. Kato S; Uetake H; Iida S; Higuchi T; Ishikawa T; Yasuno M; Enomoto M; Sugihara K Gan To Kagaku Ryoho; 2006 Nov; 33(12):1798-800. PubMed ID: 17212111 [TBL] [Abstract][Full Text] [Related]
46. [Hemodynamics at hepatoarterial infusion of 5-FU in a chronic renal failure patient maintained by hemodialysis]. Maruyama M; Irie T; Yoshida T; Nagahama T; Sugano N; Ebuchi M Gan To Kagaku Ryoho; 1999 Dec; 26(14):2241-5. PubMed ID: 10635312 [TBL] [Abstract][Full Text] [Related]
47. RNA labelling with 3H-orotic acid and 3H-fluorouracil of rat liver tumour following transient hepatic arterial ischaemia. Mack P; Tranberg KG; Strenram U; Jeppsson B; Widlus D; Bengmark S Eur J Surg Oncol; 1988 Dec; 14(6):669-75. PubMed ID: 3192004 [TBL] [Abstract][Full Text] [Related]
48. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829 [TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation. Fanciullino R; Giacometti S; Mercier C; Aubert C; Blanquicett C; Piccerelle P; Ciccolini J Br J Cancer; 2007 Oct; 97(7):919-26. PubMed ID: 17848948 [TBL] [Abstract][Full Text] [Related]
51. Intratumoural thymidylate synthase and dihydropyrimidine dehydrogenase activities are good predictors of 5-fluorouracil sensitivity in colorectal cancer. Ishibiki Y; Kitajima M; Sakamoto K; Tomiki Y; Sakamoto S; Kamano T J Int Med Res; 2003; 31(3):181-7. PubMed ID: 12870370 [TBL] [Abstract][Full Text] [Related]
52. Effect of carbogen breathing on the pharmacodynamics of 5-fluorouracil in a murine colon carcinoma. Kamm YJ; Heerschap A; Wagener DJ Eur J Cancer; 2000 Jun; 36(9):1180-6. PubMed ID: 10854952 [TBL] [Abstract][Full Text] [Related]
53. Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis. Bras-Gonçalves RA; Pocard M; Formento JL; Poirson-Bichat F; De Pinieux G; Pandrea I; Arvelo F; Ronco G; Villa P; Coquelle A; Milano G; Lesuffleur T; Dutrillaux B; Poupon MF Gastroenterology; 2001 Mar; 120(4):874-88. PubMed ID: 11231942 [TBL] [Abstract][Full Text] [Related]
54. A predictive biomarker for altered 5-fluorouracil pharmacokinetics following repeated administration in a rat model of colorectal cancer. Kobuchi S; Kuwano S; Imoto K; Okada K; Nishimura A; Ito Y; Shibata N; Takada K Biopharm Drug Dispos; 2013 Oct; 34(7):365-76. PubMed ID: 23836081 [TBL] [Abstract][Full Text] [Related]
55. [Chemotherapy for liver metastasis of colorectal cancer]. Amano M; Niinobu T; Itani Y; Nishikawa Y; Nakagawa S; Higaki N; Hayashida H; Fujita M; Sakon M Gan To Kagaku Ryoho; 2005 Oct; 32(11):1721-3. PubMed ID: 16315920 [TBL] [Abstract][Full Text] [Related]
56. Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. Murakami Y; Kazuno H; Emura T; Tsujimoto H; Suzuki N; Fukushima M Int J Oncol; 2000 Aug; 17(2):277-83. PubMed ID: 10891536 [TBL] [Abstract][Full Text] [Related]
57. Perfusion of colorectal liver metastases and uptake of fluorouracil assessed by H2(15)O and [18F]uracil positron emission tomography (PET). Hohenberger P; Strauss LG; Lehner B; Frohmüller S; Dimitrakopoulou A; Schlag P Eur J Cancer; 1993; 29A(12):1682-6. PubMed ID: 8398294 [TBL] [Abstract][Full Text] [Related]
58. [Switching to direct intrahepatic arterial infusion of 5-FU after a progression of liver metastases from colorectal carcinoma treated with systemic infusion of FOLFOX]. Kikuoka S; Miura T; Takeuchi I; Miura T; Akamatsu N; Ishida F; Ozawa F; Moriguchi M Gan To Kagaku Ryoho; 2009 Nov; 36(12):2036-8. PubMed ID: 20037315 [TBL] [Abstract][Full Text] [Related]
59. Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts. Smith JP; Kanekal S; Patawaran MB; Chen JY; Jones RE; Orenberg EK; Yu NY Cancer Chemother Pharmacol; 1999; 44(4):267-74. PubMed ID: 10447573 [TBL] [Abstract][Full Text] [Related]
60. Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer. Aboagye EO; Saleem A; Cunningham VJ; Osman S; Price PM Cancer Res; 2001 Jul; 61(13):4937-41. PubMed ID: 11431319 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]